Rolf Hoffmann is a Strategic and results-orientated Executive who is highly respected for expertise in creating and optimizing commercial opportunities in all global markets. He has over 29 years of experience managing top 50 worldwide markets …

2023年5月29日 · Rolf Hoffmann is a Strategic and results-orientated Executive who is highly respected for expertise in creating and optimizing commercial opportunities in all global markets. He has over 29 years of experience managing top 50 worldwide markets with full P&L and cross-functional accountability.

2022年4月19日 · Rolf Hoffmann is the Chief Financial Officer for Bayer South Asia since July 1, 2019. On the same date, he was appointed as a Whole-Time Director for Bayer CropScience Limited.

2023年6月13日 · Sun Pharma's board of directors recently approved the appointment of Rolf Hoffmann as an independent director for a term of five years.

RepliCel’s co-founders, Kevin McElwee and Rolf Hoffmann, continue to contribute to the Company’s science and strategy complemented now by an outstanding panel of nationally and globally renowned clinical advisors in Europe, North America, and Asia.

2024年10月4日 · As of 2021, Rolf Hoffmann is the Chief Operating Officer (COO) of Sony Music Entertainment Inc. Prior to his appointment as COO, Hoffmann served as the President and CEO of Sony Music’s...

2016年5月6日 · In 2004 Dr. Hoffmann was appointed executive director of the Fulbright Commission in Berlin and helmed its academic exchange programs between the U.S. and Germany.

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Oct. 13, 2004--Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced the appointment of Rolf Hoffmann to the position of senior vice president, Amgen Europe.

2018年4月19日 · Shield Therapeutics, a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, has appointed Rolf Hoffman as Non-Executive Director following a successful executive search conducted by The RSA Group.